by Riley Nolan | May 21, 2021 | Events, Featured, Webinars
EpiVax CEO/CSO Annie De Groot and Director of Analysis Frances Terry co-presented “Engineering Better Biologics: Does Nature Know Best?” at the 2021 AAPS NBC conference May 19th 2021. Outline: Background on T cells / Immunogenicity EpiMatrix, JanusMatrix ...
by Riley Nolan | Mar 11, 2021 | Events, Featured, Webinars
Aimee Mattei, Senior Project Manager on our Bioinformatics team, will be presenting to the AAPS BPABC(biopharmaceutical product attributes and biological consequences) Community on March 18th at 12pm ET. You’ll need to join the group to register, membership is...
by Riley Nolan | Feb 17, 2021 | Events, Featured, Webinars
EpiVax CEO/CSO Annie De Groot hosted a talk for the FDA Office of Tissues and Advanced Therapies (OTAT) group on February 11, 2021. Annie presented the latest on EpiVax’s iVAX Toolkit in her talk “Epitope Selection for Cancer Vaccines”. JanusMatrix,...
by Riley Nolan | Jan 26, 2021 | Events, Featured, Webinars
The FDA hosted a virtual workshop January 26, 2021 to provide updates and foster discussions around non-clinical assays for comparative immunogenicity risk assessment of generic peptide products. EpiVax CEO/CSO, Annie De Groot, presented an update on EpiVax’s...
by Riley Nolan | Oct 20, 2020 | Uncategorized, Webinars
We are excited to share that our very own Annie De Groot was selected as a recipient of this year’s AAPS Global Health Award! View Annie’s acceptance speech here! The American Association of Pharmaceutical Scientists(AAPS) nominates one member annually for...
by Annie De Groot | Sep 23, 2020 | Events, Webinars
Catch the replay We’re sorry, but this live event has passed. You may watch the replay here. The video is hosted by Dropbox, in which case you will need to either be logged in to an account, or downlow the video in order to view the full recording. Should you...
